SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy
8 references·1 citing·37 second hop
Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy (2019)Cyproterone acetate or spironolactone in …Sociodemographic and Clinical Characteristics of Transgender Adults in Australia (2018)Sociodemographic and Clinical…Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline (2017)Endocrine Treatment of Gender…Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study (2017)Changes in regional body fat,…Oestrogen and anti-androgen therapy for transgender women (2016)Oestrogen and anti-androgen t…Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness (2016)Cyproterone acetate vs leupro…A Systematic Review of the Effects of Hormone Therapy on Psychological Functioning and Quality of Life in Transgender Individuals (2016)A Systematic Review of the Ef…A European Network for the Investigation of Gender Incongruence: Endocrine Part (2016)A European Network for the In…Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism (1989)Spironolactone with physiolog…Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study (2021)Toward a Lowest Effective Dos…TRANSSEXUALISM AND SEX REASSIGNMENT (1970)Endocrine Therapy of Transsexualism and Potential Complications of Long-Term Treatment (1998)Endocrine intervention for transsexuals (2003)Breast Development in Transwomen After 1 Year of Cross-Sex Hormone Therapy: Results of a Prospective Multicenter Study (2017)Cochrane Handbook for Systematic Reviews of Interventions (2008)Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement (2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement (2009)Demographic and temporal trends in transgender identities and gender confirming surgery (2019)Associations between minority stress, depression, and suicidal ideation and attempts in transgender and gender diverse (TGD) individuals: Systematic review and meta-analysis (2021)Hormone Therapy, Mental Health, and Quality of Life Among Transgender People: A Systematic Review (2021)The MOS 36-ltem Short-Form Health Survey (SF-36): III. Tests of Data Quality, Scaling Assumptions, and Reliability Across Diverse Patient Groups (1994)Endocrine Treatment of Transsexual Persons:An Endocrine Society Clinical Practice Guideline (2009)Diagnostic and Statistical Manual of Mental Disorders (2013)Transient Elevated Serum Prolactin in Trans Women Is Caused by Cyproterone Acetate Treatment (2017)Bone Mass Effects of Cross-Sex Hormone Therapy in Transgender People: Updated Systematic Review and Meta-Analysis (2019)Gender affirming medical care of transgender youth (2019)Development and validation of brief measures of positive and negative affect: The PANAS scales. (1988)Development and validation of brief measures of positive and negative affect: The PANAS scales. (1988)Diagnostic and Statistical Manual of Mental Disorders (2013)Fertility treatment for the transgender community: a public opinion study (2017)A systematic review of psychosocial functioning changes after gender-affirming hormone therapy among transgender people (2023)Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 (2012)Barriers to healthcare for transgender individuals (2016)Cohort profile: Study of Transition, Outcomes and Gender (STRONG) to assess health status of transgender people (2017)Gender-affirming hormones and surgery in transgender children and adolescents (2018)The Perioperative Care of the Transgender Patient (2018)Cross-Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short-Time Follow-Up: Results from the European Network for the Investigation of Gender Incongruence (2014)Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria (2021)Gender‐affirming hormone therapy: An updated literature review with an eye on the future (2022)Mortality and morbidity in transsexual patients with cross-gender hormone treatment (1989)The Amsterdam Cohort of Gender Dysphoria Study (1972–2015): Trends in Prevalence, Treatment, and Regrets (2018)Cross-sex Hormones and Acute Cardiovascular Events in Transgender Persons (2018)Ensuring Comprehensive Care and Support for Transgender and Gender-Diverse Children and Adolescents (2018)Pubertal Suppression for Transgender Youth and Risk of Suicidal Ideation (2020)Position statement on the hormonal management of adult transgender and gender diverse individuals (2019)Non-Binary and Binary Gender Identity in Australian Trans and Gender Diverse Individuals (2020)In Addition to Stigma: Cognitive and Autism-Related Predictors of Mental Health in Transgender Adolescents (2021)
this work references cited by second hop

References

  • 2017Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline2,326 cited
  • 2016A Systematic Review of the Effects of Hormone Therapy on Psychological Functioning and Quality of Life in Transgender Individuals405 cited
  • 2016Oestrogen and anti-androgen therapy for transgender women208 cited
  • 2017Changes in regional body fat, lean body mass and body shape in trans persons using cross-sex hormonal therapy: results from a multicenter prospective study198 cited
  • 2018Sociodemographic and Clinical Characteristics of Transgender Adults in Australia136 cited
  • 2016A European Network for the Investigation of Gender Incongruence: Endocrine Part133 cited
  • 1989Spironolactone with physiological female steroids for presurgical therapy of male-to-female transsexualism109 cited
  • 2016Cyproterone acetate vs leuprolide acetate in combination with transdermal oestradiol in transwomen: a comparison of safety and effectiveness83 cited

Cited by

  • 2021Toward a Lowest Effective Dose of Cyproterone Acetate in Trans Women: Results From the ENIGI Study62 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work